Clinical Research Coordinator - Beroukhim and Ligon Labs

A position is available for a data-oriented Clinical Research Coordinator in the labs of Dr. Rameen Beroukhim and Dr. Keith Ligon. This position will support the exciting precision medicine work of the Breakthrough Cancer (BTC) and DFCI collaboration. The research lies at the interface between clinical medicine and high-throughput genomics and spans multiple cancers, including glioblastomas, leukemias, pancreatic cancers, and ovarian cancers.

The candidate will interface with a wide range of clinical and laboratory-based researchers across the Dana‑Farber Cancer Institute, MIT, Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, Johns Hopkins University, and other institutions.

The candidate will work to facilitate translational biomarker‑driven research by applying tissue and data management skills. The position involves research in clinical trials, including those of novel immunotherapies and targeted therapies for brain tumors. The position will also provide applicants with outstanding opportunities for interaction and collaboration with physicians, clinical research staff, and basic researchers in a dynamic and exciting environment.

This position is considering 2026 bachelor’s degree graduates.

Located in Boston and the surrounding communities, Dana‑Farber Cancer Institute is a leader in life‑changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS, and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high‑risk and underserved populations.

We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical School‑affiliated hospitals.

• Oversight of the clinical trials start‑up process from receipt of protocols through the Scientific Review Committee and IRB submissions, and site activation activities.
• Responsible for data reporting and management, collection of source documents, use and development of case report forms, adverse events reporting, filing, and archiving of study records, and resolution of data queries.
• May prepare and or complete regulatory related reports and IRB submissions. Maintain and organize study participant/subject trial binder and regulatory binders, enter all required study data on an ongoing basis and as applicable.
• Ensure all study related samples are collected, properly prepared, and shipped according to the protocol requirements and IATA/DOT regulations.
• Collaborate with other departments such as Protocol Scheduling, Materials Management, the Clinical Research Laboratory, Pharmacy, Research Nursing, and other departments, as needed per the requirements of the clinical trial.
• Responsible for organizing and preparing for both internal and external auditing and study monitoring visits.
• Coordination and management of clinical trials throughout the trial life cycle, including communication with sponsors and regulatory authorities.
• Close‑out of clinical trials, including contributing to research articles, audit preparation, and communication with regulatory agencies and other disciplines involved.
• Interact with study participants as directed/required by the protocol and/or study team.
• May be responsible for tissue sample collection per trial requirements.
• Responsible for data entry of Subject Visit Tracking information into Clinical Trial Management System contemporaneously with medical visits, assessments, and other subject‑specific information.
• Responsible for data entry of time and effort spent on study‑specific activities and other administrative tasks into Clinical Trial Management System contemporaneously with work completed.
• Responsible for data entry of study‑specific activity, including but not limited to monitor visits, external site enrollment, amendments, receipt of Safety Reports, etc. into Clinical Trial Management System contemporaneously with activity completed.

• B…